The clock is ticking for Takeda (NASDAQOTH: TKPYY). Following its announcement late last month that it's considering an acquisition of Shire (NASDAQ: SHPG), it has until April 25, 2018, to present the latter's board of directors with an offer or walk away empty-handed. If it does make a bid, it could create a global company with about $30 billion in sales.
However, this deal could be costly. In this episode of The Motley Fool's Industry Focus: Healthcare , analyst Kristine Harjes chats with Todd Campbell about this potential deal and whether it might make sense.Will Shire Be Bought Out?
Понравилась статья? Подпишитесь на канал, чтобы быть в курсе самых интересных материалов
Подписаться